Table 3.
Baseline and in-hospital clinical characteristics in relation to the presence of multi-vessel diseases.
| Multi-Vessel Disease (76 Patients) | No Multi-Vessel Disease (136 Patients) | p-Value | |
|---|---|---|---|
| Baseline presentation | |||
| ST-elevation MI 1 (%) | 26 | 33 | 0.35 |
| Age (years) | 67 ± 10 | 67 ± 12 | 0.72 |
| Male gender (%) | 71 | 64 | 0.36 |
| Hypertension history (%) | 72 | 82 | 0.11 |
| Diabetes history (%) | 41 | 34 | 0.37 |
| COPD history 2 (%) | 8 | 13 | 0.27 |
| Smoking (%) | 46 | 44 | 0.89 |
| Stroke history (%) | 7 | 10 | 0.61 |
| MI history (%) | 24 | 26 | 0.74 |
| Low-risk (%) | 0 | 40 | <0.001 |
| In-hospital characteristics | |||
| Length of hospital stay (d) | 8 (Q1: 7; Q3: 10) | 7 (Q1: 5; Q3: 9) | <0.001 |
| LVEF 3 (%) | 45 (Q1: 39; Q3: 55) | 50 (Q1: 40; Q3: 58) | 0.14 |
| LAD 4 culprit (%) | 34 | 38 | 0.66 |
| Staged revascularization (%) | 54 | 4 | <0.001 |
| Ventricular arrhythmia (%) | 9 | 7 | 0.61 |
| GFR 5 (mL/min/1.73 m2) | 81 ± 35 | 76 ± 30 | 0.31 |
| RBC 6 transfusion (%) | 3 | 4 | 0.71 |
| Respiratory infections (%) | 16 | 15 | 1.0 |
| ACEI/ARB 7 (%) | 77 | 84 | 0.27 |
| B-blocker (%) | 83 | 82 | 1.0 |
| Loop diuretics (%) | 33 | 40 | 0.37 |
| Aldosterone antagonists (%) | 17 | 24 | 0.29 |
1 myocardial infarction; 2 chronic obstructive pulmonary disease; 3 left ventricular ejection fraction; 4 left anterior descending artery; 5 glomerular filtration rate; 6 red blood cell; 7 angiotensin converting enzyme inhibitor, angiotensin receptor blocker.